Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Hypertension. 2014 Feb 10;63(5):951–957. doi: 10.1161/HYPERTENSIONAHA.113.02767

Figure 2.

Figure 2

Effect of treatment on forearm blood flow (FBF) response to intra-arterial bradykinin, with and without intra-arterial enalaprilat, and to substance P, with and without intra-arterial enalaprilat (n=12). Data presented as mean ± standard error of the mean. Quadratic model-based p-values presented in the text. *p<0.05 versus placebo at same peptide dose, †p<0.05 versus dipeptidyl peptidase-4 inhibition (DPP4i) at same peptide dose, ACEi indicates angiotensin-converting enzyme inhibition.